Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
depression
3
×
neuroscience
3
×
biotech
boston
boston blog main
boston top stories
life sciences
major depressive disorder
national blog main
national top stories
sage therapeutics
aligos therapeutics
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
brain
brain scans
brexanalone
cavion
cephalgia
chronic hepatitis b virus
clinical data
clinical trials
cognitive neuroscience
connectome
david goldstein
demodex blepharitis
epilepsy
essential tremor
eventide asset management
extreme
fda
fmri
hepatitis b
horowitz group
isoxazolines
jazz pharmaceuticals
jeff jonas
What
depression
research
appeared
approval
biotechs
brexanalone
central
change
cns
cornell
diagnose
disease
disorder
distinct
drug
drugs
emerged
extremetech
fda
finds
fmri
groundbreaking
hits
hour
illnesses.the
infusion
ipos
isolates
kept
leads
light
mark
medical
medicines
mental
nervous
neurological
neurotypes
new
phase
Language
unset
Current search:
depression
×
neuroscience
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@extremetech.com
7 years ago
Groundbreaking fMRI study finds 4 distinct neurological subtypes of depression
